403 related articles for article (PubMed ID: 18584356)
21. Cutaneous chronic graft-versus-host disease localized to the field of total lymphoid irradiation.
Okamoto S; Takahashi S; Inoue T; Tojo A; Tani K; Kikuchi A; Shimizu H; Nishikawa T; Ikeda Y; Asano S
Bone Marrow Transplant; 1996 Jan; 17(1):111-3. PubMed ID: 8673042
[TBL] [Abstract][Full Text] [Related]
22. Partial reconstitution of cutaneous microvessels in long-term survivors after allogeneic bone marrow transplantation.
Haeusermann P; Kump E; Rovó A; Tichelli A; Itin P; Gratwohl A; Biedermann BC
Dermatology; 2009; 219(1):32-41. PubMed ID: 19407437
[TBL] [Abstract][Full Text] [Related]
23. Ocular manifestations of graft versus host disease following bone marrow transplantation.
Claes K; Kestelyn P
Bull Soc Belge Ophtalmol; 2000; (277):21-6. PubMed ID: 11126670
[TBL] [Abstract][Full Text] [Related]
24. Acute graft-versus-host disease of the heart.
Roberts SS; Leeborg N; Loriaux M; Johnson FL; Huang ML; Stenzel P; Thiede C; Godder KT
Pediatr Blood Cancer; 2006 Oct; 47(5):624-8. PubMed ID: 16206193
[TBL] [Abstract][Full Text] [Related]
25. Beneficial effect of intravenous lidocaine in cutaneous chronic graft-versus-host disease secondary to donor lymphocyte infusion.
Voltarelli JC; Ahmed H; Paton EJ; Stracieri AB; Holman P; Bashey A; Coutinho M; Simoes BP; Ball ED; Carrier E
Bone Marrow Transplant; 2001 Jul; 28(1):97-9. PubMed ID: 11498752
[TBL] [Abstract][Full Text] [Related]
26. Renal involvement in chronic graft-versus-host disease: a report of two cases.
Gomez-Garcia P; Herrera-Arroyo C; Torres-Gomez A; Gomez-Carrasco J; Aljama-Garcia P; Lopez-Rubio F; Martinez-Guibelalde F; Fornes-Torres G; Rojas-Contreras R
Bone Marrow Transplant; 1988 Jul; 3(4):357-62. PubMed ID: 3048498
[TBL] [Abstract][Full Text] [Related]
27. Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease.
Olson KA; West K; McCarthy PL
Pharmacotherapy; 2014 Jun; 34(6):e60-4. PubMed ID: 24700567
[TBL] [Abstract][Full Text] [Related]
28. Acute follicular graft-vs-host reaction. A distinct clinicopathologic presentation.
Friedman KJ; LeBoit PE; Farmer ER
Arch Dermatol; 1988 May; 124(5):688-91. PubMed ID: 3284466
[TBL] [Abstract][Full Text] [Related]
29. [A case with myositis as a manifestation of chronic graft-versus-host-disease (GVHD) with severe muscle swelling developed after aggressive muscular exercise].
Kano S; Shimizu J; Mikata T; Shinoe T; Ota H; Komeno Y; Ogawa S; Hirai H; Kanazawa I
Rinsho Shinkeigaku; 2003 Mar; 43(3):93-7. PubMed ID: 12820556
[TBL] [Abstract][Full Text] [Related]
30. Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation.
Karwacka E; Ołdakowska-Jedynak U; Brydak-Godowska J; Paczek L; Kecik D
Transplant Proc; 2006; 38(1):292-4. PubMed ID: 16504728
[TBL] [Abstract][Full Text] [Related]
31. Rapamycin for Kaposi's sarcoma and graft-versus-host disease in bone marrow transplant recipient.
Marco de F; Infante B; Giovanni S; Gesualdo L
Transplantation; 2010 Mar; 89(5):633-4. PubMed ID: 20216371
[No Abstract] [Full Text] [Related]
32. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
33. Unexplained effusions: association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease.
Pretnar J; Cernelc P; Mlakar U; Fortuna M
Bone Marrow Transplant; 1996 Oct; 18(4):826. PubMed ID: 8899209
[No Abstract] [Full Text] [Related]
34. Chronic demyelinating polyneuropathy in graft-versus-host disease following allogeneic bone marrow transplantation.
Nagashima T; Sato F; Chuma T; Mano Y; Sasaki I; Mori M; Higa T; Masauji N; Kasai M; Orba Y; Shinohara T; Nagashima K
Neuropathology; 2002 Mar; 22(1):1-8. PubMed ID: 12030409
[TBL] [Abstract][Full Text] [Related]
35. [PUVA therapy for cutaneous acute graft-versus-host disease--a case report].
Inamitsu T; Inoue M; Akiyoshi H; Honda K; Shibuya T; Nakayama H; Ueda K
Rinsho Ketsueki; 1995 Nov; 36(11):1321-5. PubMed ID: 8691576
[TBL] [Abstract][Full Text] [Related]
36. Esophageal graft versus host disease.
Sodhi SS; Srinivasan R; Thomas RM
Gastrointest Endosc; 2000 Aug; 52(2):235. PubMed ID: 10922099
[No Abstract] [Full Text] [Related]
37. Organ tolerance following cadaveric liver transplantation for chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Urban CH; Deutschmann A; Kerbl R; Lackner H; Schwinger W; Königsrainer A; Margreiter R
Bone Marrow Transplant; 2002 Oct; 30(8):535-7. PubMed ID: 12379895
[TBL] [Abstract][Full Text] [Related]
38. Lichenoid chronic graft-vs-host disease occurring in a dermatomal distribution.
Freemer CS; Farmer ER; Corio RL; Altomonte VL; Wagner JE; Vogelsang GB; Santos GW
Arch Dermatol; 1994 Jan; 130(1):70-2. PubMed ID: 8285743
[TBL] [Abstract][Full Text] [Related]
39. [The skin manifestations of the graft vs. host reaction].
Biriukov AV; Baranov AE; Selidovkin GD; Evseeva LV; Getling ZM; Persina IS
Vestn Dermatol Venerol; 1990; (5):16-9. PubMed ID: 2402935
[TBL] [Abstract][Full Text] [Related]
40. Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft-versus-host disease.
Marra DE; McKee PH; Nghiem P
J Am Acad Dermatol; 2004 Oct; 51(4):543-6. PubMed ID: 15389188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]